Anti-CO9A1/ COL9A1/ DJ149L1.1.2 functional antibody

Anti-CO9A1/ COL9A1/ DJ149L1.1.2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to COL9A1/COL9A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0616-Ab-1/ GM-Tg-hg-SE0616-Ab-2Anti-Human COL9A1 monoclonal antibodyHuman
GM-Tg-rg-SE0616-Ab-1/ GM-Tg-rg-SE0616-Ab-2Anti-Rat COL9A1 monoclonal antibodyRat
GM-Tg-mg-SE0616-Ab-1/ GM-Tg-mg-SE0616-Ab-2Anti-Mouse COL9A1 monoclonal antibodyMouse
GM-Tg-cynog-SE0616-Ab-1/ GM-Tg-cynog-SE0616-Ab-2Anti-Cynomolgus/ Rhesus macaque COL9A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0616-Ab-1/ GM-Tg-felg-SE0616-Ab-2Anti-Feline COL9A1 monoclonal antibodyFeline
GM-Tg-cang-SE0616-Ab-1/ GM-Tg-cang-SE0616-Ab-2Anti-Canine COL9A1 monoclonal antibodyCanine
GM-Tg-bovg-SE0616-Ab-1/ GM-Tg-bovg-SE0616-Ab-2Anti-Bovine COL9A1 monoclonal antibodyBovine
GM-Tg-equg-SE0616-Ab-1/ GM-Tg-equg-SE0616-Ab-2Anti-Equine COL9A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0616-Ab-1/ GM-Tg-hg-SE0616-Ab-2; GM-Tg-rg-SE0616-Ab-1/ GM-Tg-rg-SE0616-Ab-2;
GM-Tg-mg-SE0616-Ab-1/ GM-Tg-mg-SE0616-Ab-2; GM-Tg-cynog-SE0616-Ab-1/ GM-Tg-cynog-SE0616-Ab-2;
GM-Tg-felg-SE0616-Ab-1/ GM-Tg-felg-SE0616-Ab-2; GM-Tg-cang-SE0616-Ab-1/ GM-Tg-cang-SE0616-Ab-2;
GM-Tg-bovg-SE0616-Ab-1/ GM-Tg-bovg-SE0616-Ab-2; GM-Tg-equg-SE0616-Ab-1/ GM-Tg-equg-SE0616-Ab-2
Products NameAnti-COL9A1 monoclonal antibody
Formatmab
Target NameCOL9A1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-COL9A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0616-Ag-1Recombinant multi-species CO9A1/ COL9A1/ DJ149L1.1.2 protein


    Target information

    Target IDGM-SE0616
    Target NameCOL9A1
    Gene ID1297,12839,305104,714809,481873,101086148,282195,100057208
    Gene Symbol and SynonymsCol9a-1,COL9A1,DJ149L1.1.2,EDM6,MED,STL4
    Uniprot AccessionP20849,P20850
    Uniprot Entry NameCO9A1_HUMAN,CO9A1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112280
    Target ClassificationN/A

    The target: COL9A1, gene name: COL9A1, also named as DJ149L1.1.2, EDM6, MED, STL4. This gene encodes one of the three alpha chains of type IX collagen, which is a minor (5-20%) collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene are associated with osteoarthritis in humans, with multiple epiphyseal dysplasia, 6, a form of chondrodysplasia, and with Stickler syndrome, a disease characterized by ophthalmic, orofacial, articular, and auditory defects. Two transcript variants that encode different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.